Platform Degenerative Diseases
Two different types of pluripotent stem cells are in the focus of the platform Degenerative Diseases (formerly Stem Cell Biology Unit): induced pluripotent stem cells (iPS cells) and embryonic stem cells (ES cells). Pluripotent stem cells could become important in the future regarding novel therapeutic approaches to the treatment of serious human diseases. In addition, we are interested in primate germ cell development and aspects of early embryonic development.
Hence, our work has (pre-) clinical relevance as well as basic cell biological and developmental aspects. However, it is important to note that understanding of basic biological mechanisms is a precondition to develop new therapeutic strategies.